Back to Search
DAVID HARDIN, MD
MD
General Practice Physician
NPI: 1801836069IndividualAccepts Medicare
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
01039780A(IN)
Physical Medicine & Rehabilitation Physician
Physical Medicine & Rehabilitation
Code: 208100000X
44907(TN)01039780A(IN)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
01039780A(IN)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 1985
Research & Publications (20)
Use of the insulin pump in treat cystic fibrosis related diabetes.
PMID 19162566·J Cyst Fibros·2009
8-other
Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
PMID 18438330·Pediatr Endocrinol Rev·2008
6-review
Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes.
PMID 18418124·J Investig Med·2008
8-other
A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth.
PMID 18174725·Horm Res·2007
6-review
Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers.
PMID 17475983·Clin Pediatr (Phila)·2007
6-review
Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
PMID 17201806·Clin Endocrinol (Oxf)·2007
8-other
Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial.
PMID 17018651·J Clin Endocrinol Metab·2006
4-observational
Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection.
PMID 16117811·Clin Endocrinol (Oxf)·2005
8-other
The metabolic effects of pregnancy in cystic fibrosis.
PMID 16055589·Obstet Gynecol·2005
4-observational
Growth hormone improves bone mineral content in children with cystic fibrosis.
PMID 16042327·J Pediatr Endocrinol Metab·2005
3-trial
A retrospective study of growth hormone use in adolescents with cystic fibrosis.
PMID 15853825·Clin Endocrinol (Oxf)·2005
8-other
GH improves growth and clinical status in children with cystic fibrosis -- a review of published studies.
PMID 15339250·Eur J Endocrinol·2004
6-review
Protease inhibitor therapy improves protein catabolism in prepubertal children with HIV infection.
PMID 15112908·J Pediatr Endocrinol Metab·2004
4-observational
Growth hormone treatment in children with cystic fibrosis.
PMID 12244275·Minerva Pediatr·2002
6-review
Growth problems and growth hormone treatment in children with cystic fibrosis.
PMID 12092687·J Pediatr Endocrinol Metab·2002
6-review
Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial.
PMID 11713439·J Pediatr·2001
3-trial
Mechanisms of insulin resistance in cystic fibrosis.
PMID 11595659·Am J Physiol Endocrinol Metab·2001
8-other
Growth hormone decreases protein catabolism in children with cystic fibrosis.
PMID 11549686·J Clin Endocrinol Metab·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 8355 ROCKVILLE RD STE 120
INDIANAPOLIS, IN 46234 - Phone
- (317) 429-0061
Quick Facts
- NPI
- 1801836069
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile